BioSig Technologies, Inc Stock News

Westport, CT, June 08, 2020 -- Company to provide updates on the initiation of human trials for treatment of adult hospitalized patients with COVID-19Phase II clinical trial.

Anavex progresses with its ANAVEX 2-73 trial. BioSig adds to its patent portfolio. Inovio's COVID-19 vaccine candidate supply line in trouble.

The hospital is part of St. David’s HealthCare, one of the largest healthcare systems in Texas. The Company intends to commence its Phase II clinical trial for merimepodib, its broad-spectrum oral

Westport, CT, Jun 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company...

Westport, CT, June 04, 2020 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical.

Westport, CT, June 03, 2020 -- U.S. Patent and Trademark Office awards Company additional patent for PURE EP™ System Five patent applications filed by ViralClear.

Westport, CT, June 01, 2020 -- Company to provide updates on the initiation of human trials for treatment of adult hospitalized patients with COVID-19Phase II clinical trial.

The

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today appointed Mr. Michael R. Dougherty to the Board of Directors of its majority-owned

Trials for vaccines and drugs to fight coronavirus dominated the news this week as funding ramped up and several pharma firms announced positive signs from their studies. Here are the biggest COVID-19

Westport, CT, May 20, 2020 -- Funding completed in subsidiary without dilution to BioSig common stockPhase II human trials for merimepodib, a broad-spectrum oral anti-viral.

Westport, CT, May 18, 2020 -- Phase II clinical trial expected to be conducted at multiple centers in the United States, including three Mayo Clinic sites under the leadership.

BioSig Technologies, Inc. (Nasdaq: BSGM) today announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination with the adenosine analogue remdesivir reduces SARS-CoV-2 re

Stocks Analysis by Harry Boxer covering: Novavax Inc, Overstockcom Inc, United Natural Foods Inc, B&G Foods Inc. Read Harry Boxer's latest article on Investing.com

The